{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-051790","form_type":"8-K","ticker":"IOBTQ","cik":"0001865494","company_name":"IO Biotech, Inc.","filed_at":"2026-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.604715+00:00","generated_at":"2026-05-16T02:49:52.930637+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"confidence":"high","headline":"IO Biotech receives Nasdaq MVLS deficiency notice; 180 days to comply","bullets":["Notice received Feb 12, 2026; MVLS below $50M for 30 consecutive business days.","Company has until August 11, 2026 to regain compliance.","Stock continues trading on Nasdaq Global Select Market during cure period.","If not cured, Nasdaq will issue delisting notice; company may appeal.","No assurance of regaining compliance with MVLS or other listing rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-051790","json":"https://secwatch.observer/filing/0001193125-26-051790.json","markdown":"https://secwatch.observer/filing/0001193125-26-051790.md","text":"https://secwatch.observer/filing/0001193125-26-051790.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865494/000119312526051790/0001193125-26-051790-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865494/000119312526051790/d113832d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:49:52.930637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}